NAD Direct Review 2026: Clinic-Grade NAD+ Supplements from a CQC-Regulated Group

Quick verdict: NAD Direct is the clinical arm of NADclinic Group, which operates 500+ medical clinics across 40+ countries and administers approximately 100,000 NAD+ infusions annually. Their oral supplement line (Enhanced Optima Max) and proprietary Smart Pen injectable sit at a premium price point, but the manufacturing credentials are among the strongest we have reviewed: GMP-certified facilities and full CQC regulation. Recommended for buyers who want clinic-level accountability in a direct-to-consumer product.

Overview

NAD Direct is the direct-to-consumer division of NADclinic Group, a London-based clinical operation that has built one of the world's largest NAD+ therapy networks. The group's 500+ partner clinics administer an estimated 100,000 intravenous and subcutaneous NAD+ infusions annually, giving their product team a data advantage most supplement brands simply do not have: they are iterating formulas against real clinical outcomes, not just emerging literature.

The product range covers four delivery formats: oral tablets, subcutaneous injectable vials, self-injection Smart Pens, and a dermatology-grade skincare line, alongside NAD+ diagnostic tests. This review focuses on their flagship oral supplement, the Enhanced Optima Max (250 mg NAD+, £75 for a 30-day supply), which is the most directly comparable product to traditional NMN and NR supplements.

Science Review

NAD Direct formulates around direct NAD+ (nicotinamide adenine dinucleotide) rather than precursors like NMN or NR. The distinction matters: NMN and NR must be converted to NAD+ intracellularly via the salvage pathway, whereas direct NAD+ delivery bypasses those enzymatic steps. Oral bioavailability of direct NAD+ has historically been questioned, but more recent evidence supports measurable systemic increases at doses above 200 mg, including data from intravenous clinical protocols.

The company's clinical background gives this claim more credibility than typical marketing. The NADclinic network has operated IV NAD+ protocols since the early clinical adoption period, and the oral product is positioned as a maintenance bridge between infusion sessions, not a standalone replacement.

Relevant supporting literature includes Shade (2020) in Integrative Medicine on oral NAD+ bioavailability, and the Yoshino et al. (2021) Science trial. That study used NMN rather than direct NAD+, but the repletion mechanism is analogous.

Manufacturing & Regulatory Standards

This is where NAD Direct most clearly separates itself from the consumer supplement market. The company operates under two distinct quality frameworks:

• GMP-certified facilities: All oral and injectable products manufactured under Good Manufacturing Practice, meeting both UK and EU pharmaceutical standards.
• CQC regulation: The NADclinic Group is registered and regulated by the Care Quality Commission, the independent regulator of health and social care in England. This is a clinical-grade credential not held by any other NAD+ supplement brand we have reviewed.
• Clinical network validation: Formulations are used within 500+ registered medical clinics, meaning they have passed practitioner-facing scrutiny before reaching the consumer channel.

Product Range Breakdown

Enhanced Optima Max (Oral NAD+)

The entry point for most buyers. Each tablet delivers 250 mg NAD+ in a plant-based capsule with no proprietary blends. A 30-tablet supply is £75 (£2.50/day); the 90-tablet supply reduces this to £2.00/day. Subscription pricing drops it further.

• Active: 250 mg NAD+ per tablet
• Format: Tablet (30 or 90 count)
• Price: £75 / 30 days · £180 / 90 days
• Manufacturing: GMP-certified, CQC-regulated group

NAD+ Smart Pen (Injectable)

The brand's flagship innovation is a proprietary self-injection pen delivering subcutaneous NAD+ at home. Available in 1000 mg (£399, ~1 month), 2000 mg (£699, ~2 months), and 3000 mg (£999, ~3 months) supplies. This format delivers a dose bioequivalence closer to clinical IV infusions than oral supplementation, and is the only consumer product of its type we have evaluated.

MethyBlue (Methylene Blue)

A pharmaceutical-grade methylene blue supplement at £35, competitively priced relative to specialist alternatives. Positioned as a mitochondrial electron carrier complement to the NAD+ range.

Diagnostic Tests

NAD Direct offers a genuinely useful differentiation here: a £199 NAD+ Levels Test Kit, a £499 NAD BioAge Test, and a £699 NAD BioGenetic 360° genetic analysis covering 384 variants. These allow buyers to measure their baseline NAD+ status and track how it changes with supplementation, a standard of care not offered by any competitor brand.

Value Assessment

At £75 per month for oral NAD+ tablets, NAD Direct sits at the premium end of the consumer market. Comparable NMN products (which convert to NAD+ rather than delivering it directly) from brands like Longevity Box cost roughly half as much per month. The premium reflects three things: the clinical manufacturing provenance, the clinical group's regulatory overhead, and the direct NAD+ formulation itself.

For buyers primarily motivated by price, NMN-based alternatives remain the better value. For buyers who want the closest thing to a clinically administered protocol in supplement form, NAD Direct's manufacturing pedigree justifies the premium.

Who It Is For

Adults seeking the highest available manufacturing credential in a direct-to-consumer NAD+ supplement, especially those who have already explored standard NMN or NR and want to step up to clinic-backed formulations. The Smart Pen range is specifically suited to those who want injectable-level efficacy without a clinic appointment.

Who Should Approach Carefully

The injectable range (Smart Pen and NADSQ vials) requires comfort with self-injection technique. First-time users should review NAD Direct's preparation guidance thoroughly. As with all NAD+ supplements, individuals who are pregnant, breastfeeding, on chemotherapy, or with active oncological conditions should consult a physician before use.

Final Verdict

NAD Direct earns its 89/100 score on the strength of an exceptional manufacturing story: CQC regulation, GMP certification, and clinical network validation are credentials no other consumer NAD+ brand can match. The score does not reach our highest tier primarily because of the pricing premium and the absence of prominently displayed batch-level COAs. For buyers who want clinic-quality accountability, it is a clear recommendation.